glutathione mutations in sclc patients NRF2 supports non-small cell lung cancer growth independently of CBP/p300-enhanced synthesis | EMBO Reports Frontiers | Broadening horizons: research
Frontiers Broadening horizons: research on ferroptosis in lung cancer and its potential therapeutic targets JCI Suppression of the SLC7A11 glutathione axis causes synthetic lethality in KRAS mutant lung adenocarcinoma Immunotherapy in small cell lung cancer: from molecular promises to clinical challenges Journal for ImmunoTherapy of Cancer Increased antioxidative defense and reduced advanced glycation end product formation by metabolic adaptation in non small cell lung cancer patients Nature Communications Frontiers Targeting lung cancer: synergistic therapeutic strategy of cuproptosis and immunogenic cell death
Pay in 4 interest-free payments of $6.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12




